866-997-4948(US-Canada Toll Free)

Transdermal Skin Patches Market - Kingdom of Saudi Arabia (KSA) Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 81 Pages

Kingdom of Saudi Arabia Transdermal Skin Patches Market: Overview

Transdermal skin patches are medicated patches that are attached to the skin which facilitates the transfer of drug from the patch into the patient’s body over a period of time. It is a viable alternative for patients who are averse to takings drugs via pills or injections. This report analyzes the current and future prospects of the transdermal skin patches market based on product type, application, distribution channel and geography.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product type, application, distribution channel and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the transdermal skin patches market in the current and future scenario. The report also provides value chain analysis of the market that describes the sequence of activities involved, from identification of the market need to their final reach to the end users. Furthermore, the report provides Porter’s five force analysis that studies five factors and their impact on the transdermal skin patches market.

Kingdom of Saudi Arabia Transdermal Skin Patches Market: Research Methodologies

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of transdermal skin patches used in hospital pharmacies, retail pharmacies, online pharmacies, etc. in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders.

Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for product type, application, distribution channel and geography for the period 2017 to 2025. The revenue generated from product type was calculated by considering the adoption rate of transdermal skin patches in Saudi Arabia and also in other geographies, the number of product launched, average cost of products, trends in industry, and distribution channel trends, among others.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the Saudi Arabia market.

Key Players Mentioned in this Report are:

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the transdermal skin patches market include Johnson & Johnson, Novartis, Mylan, Teva Pharmaceuticals, Luye Pharma, Hisamitsu Pharmaceutical, Purdue Pharma, and Mundipharma.

The transdermal skin patches market has been segmented as follows:

Transdermal Skin Patches Market, by Product Type, Revenue (US$ Mn) 2017-2025

  • Drug in Adhesive
  • Matrix
  • Reservoir
  • Vapor

Transdermal Skin Patches Market, by Application, Revenue (US$ Mn) 2017-2025

  • Pain Relief
  • Nicotine Cessation
  • Hormone replacement therapy
  • Motion Sickness
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others

Transdermal Skin Patches Market, by Distribution Channel, Revenue (US$ Mn) 2017-2025

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Transdermal Skin Patches Market, by Geography, Revenue (US$ Mn), 2017-2025

  • Saudi Arabia

Table of Content

1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

3 Executive Summary
3.1 KSA Transdermal Skin Patches: Market Snapshot
3.2 Market Share Analysis by Application, 2016

4 Market Overview
4.1 Market Overview
4.2 Key Industry Events
4.3 KSA Transdermal Skin Patches Market: Market Outlook

5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.2.1 Increasing geriatric population
5.2.2 Ongoing developments in transdermal drug delivery system
5.2.3 Growing preference for self-administration of drugs
5.2.4 Improved efficacy as compared to other routes of drug administration
5.2.5 Increasing inclination toward pain free drug delivery
5.3 Restraints
5.3.1 Growing abuse of transdermal patches
5.3.2 Side effects associated with use transdermal patches
5.4 Opportunities
5.4.1 Increasing opportunities for generic players due to patent expiration
5.4.2 Growing areas of applications
5.5 Macro Factors Affecting Transdermal Skin Patches Market in KSA
5.5.1 Government initiatives for health care reforms
5.5.2 High prevalence of lifestyle diseases
5.5.3 Measures for encouraging investments in pharmaceutical sector
5.6 Key Trends
5.7 KSA Transdermal Skin Patches Market Size (US$ Mn) Forecast, 2017–2025
5.8 Transdermal Skin Patches Market: Porter’s Five Force Analysis
5.9 Transdermal Skin Patches Market: Supply Chain Analysis
5.10 Regulatory Scenario in Saudi Arabia
5.11 Saudi Arabia Healthcare Market Trends Analysis
5.12 Transdermal skin patch product insights
5.13 Customer Purchase: Decision Making Process
5.14 Transdermal Skin Patches Market: Analysis of Challenges for Factory Set Up
5.15 Raw material selection for transdermal skin patch manufacture
5.16 Transdermal Skin Patches Market: Factory Set Up Process
5.17 Transdermal Skin Patches Market: Market Share, by Key Players, 2016

6 KSA Transdermal Skin Patches Market Analysis, by Product Type
6.1 Introduction
6.2 KSA Transdermal Skin Patches Market Value Share Analysis, by Product Type
6.3 KSA Transdermal Skin Patches Market Forecast, by Product Type
6.3.1 Drug in Adhesive
6.3.2 Matrix
6.3.3 Reservoir
6.3.4 Vapor
6.4 Market Attractiveness Analysis, by Product Type

7 KSA Transdermal Skin Patches Market Analysis, by Application
7.1 Introduction
7.2 KSA Transdermal Skin Patches Market Value Share Analysis, by Application
7.3 KSA Transdermal Skin Patches Market Forecast, by Application
7.3.1 Pain Relief
7.3.2 Nicotine Cessation
7.3.3 Hormone replacement therapy
7.3.4 Motion Sickness
7.3.5 Neurological Disorders
7.3.6 Cardiovascular Disorders
7.3.7 Others
7.4 Market Attractiveness Analysis, by Application

8 KSA Transdermal Skin Patches Market Analysis, by Distribution Channel
8.1 Introduction
8.2 KSA Transdermal Skin Patches Market Value Share Analysis, by Distribution Channel
8.3 KSA Transdermal Skin Patches Market Forecast, by Distribution Channel
8.3.1 Hospital Pharmacies
8.3.2 Retail Pharmacies
8.3.3 Online Pharmacies
8.4 Market Attractiveness Analysis, by Distribution Channel

9 Company Profiles
9.1 Teva Pharmaceutical Industries Ltd.
9.1.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.2. Business Overview
9.1.3. Product Portfolio
9.1.4. Financial Overview
9.1.5. SWOT Analysis
9.1.6. Strategic overview
9.2 Luye Pharma Group Ltd.
9.2.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.2. Business Overview
9.2.3. Product Portfolio
9.2.4. Financial Overview
9.2.5. SWOT Analysis
9.2.6. Strategic overview
9.3 Hisamitsu Pharmaceutical Co., Inc.
9.3.1. Company Overview (HQ, Business Segments, Employee Strength)
9.3.2. Business Overview
9.3.3. Product Portfolio
9.3.4. Financial Overview
9.3.5. SWOT Analysis
9.3.6. Strategic overview
9.4 Novartis AG
9.4.1. Company Overview (HQ, Business Segments, Employee Strength)
9.4.2. Business Overview
9.4.3. Product Portfolio
9.4.4. Financial Overview
9.4.5. SWOT Analysis
9.4.6. Strategic overview
9.5 Mylan N.V.
9.5.1. Company Overview (HQ, Business Segments, Employee Strength)
9.5.2. Business Overview
9.5.3. Product Portfolio
9.5.4. Financial Overview
9.5.5. SWOT Analysis
9.5.6. Strategic overview
9.6 Johnson & Johnson
9.6.1. Company Overview (HQ, Business Segments, Employee Strength)
9.6.2. Business Overview
9.6.3. Product Portfolio
9.6.4. Financial Overview
9.6.5. SWOT Analysis
9.6.6. Strategic overview
9.7 Mundipharma International Ltd
9.7.1. Company Overview (HQ, Business Segments, Employee Strength)
9.7.2. Business Overview
9.7.3. Product Portfolio
9.7.4. Financial Overview
9.7.5. SWOT Analysis
9.7.6. Strategic overview
9.8 Purdue Pharma L.P.
9.8.1. Company Overview (HQ, Business Segments, Employee Strength)
9.8.2. Business Overview
9.8.3. Product Portfolio
9.8.4. Financial Overview
9.8.5. SWOT Analysis
9.8.6. Strategic overview

List of Table

Table 01: Transdermal Skin Patches Market Size (US$ Mn) Forecast, by Product Type, 2015–2025

Table 02: Transdermal Skin Patches Market Size (US$ Mn) Forecast, by Application, 2015–2025

Table 03: Transdermal Skin Patches Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

List of Chart

Figure 01: Saudi Arabia Transdermal Skin Patches Market Size (US$ Mn) Forecast, 2017–2025

Figure 02: Transdermal Skin Patches Market Value Share Analysis, by Product Type, 2017 and 2025

Figure 03: KSA Drug in Adhesive Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 04: KSA Matrix Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 05: KSA Reservoir Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 06: KSA Vapor Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 07: Transdermal Skin Patches Market Attractiveness Analysis, by Product Type, 2016

Figure 08: Transdermal Skin Patches Market Value Share Analysis, by Application, 2017 and 2025

Figure 09: KSA Pain Relief Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 10: KSA Nicotine Cessation Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 11: KSA Hormone replacement therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 12: KSA Motion Sickness Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 13: KSA Neurological Disorders Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 14: KSA Cardiovascular Disorders Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 15: KSA Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025

Figure 16: Transdermal Skin Patches Market Attractiveness Analysis, by Application, 2015

Figure 17: Transdermal Skin Patches Market Value Share Analysis, by Distribution Channel, 2017 and 2025

Figure 18: KSA Hospital Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2025

Figure 19: KSA Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2025

Figure 20: KSA Online Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2025

Figure 21: Transdermal Skin Patches Market Attractiveness Analysis, by Distribution Channel, 2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *